Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Midazolam for Continuous Sedation of Ventilated Patients in Intensive Care Unit

NCT00481312 is registered in ClinicalTrials.gov with Orion Corporation, Orion Pharma as lead sponsor.

NCT NCT00481312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00481312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Midazolam for Continuous Sedation of Ventilated Patients in Intensive Care Unit
Lead sponsor
Orion Corporation, Orion Pharma
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2007
Completion date
October 31, 2009
Enrollment
501 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

continuous sedation in initially sedated adults in icu